Ardent Health prices $14.50 secondary offering and plans share repurchase

Ardent Health priced a secondary sale of 8,000,000 shares at $14.50 each on November 18, 2026. Affiliates of Equity Group Investments and Ventas are selling the stock, while Ardent plans to buy 1,500,000 shares from the underwriters using cash on hand. The transaction is scheduled to settle on November 19, 2026, if standard closing requirements are met, and Ardent will not receive money from the secondary sale.

The sale provides liquidity to existing stockholders but creates additional shares available to the market. Ardent's separate repurchase uses cash and does not reduce the capacity of its previously announced buyback plan.

  • 1The secondary transaction covers 8,000,000 Ardent shares priced at $14.50 per share.
  • 2Equity Group Investments' affiliate is selling 7,136,719 shares and Ventas' affiliate is selling 863,281 shares.
  • 3Underwriters have a 30-day right to purchase up to an additional 1,200,000 shares at the public offering price, less underwriting discounts and commissions.
  • 4Ardent will repurchase 1,500,000 shares from the underwriters at the price paid to the selling stockholders and will fund that purchase with existing cash.
  • 5The transaction is expected to close on November 19, 2026, subject to standard closing requirements.

Sources